This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Malgache De Recherche Appliquee, Muséum National D'histoire Naturelle. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2011
Title: Akino Jossang: Innovator in Anti-Malarial Drug Development
Introduction
Akino Jossang is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-malarial drugs. His innovative work has the potential to impact global health positively.
Latest Patents
Jossang holds a patent for alkaloid compounds and their use as anti-malarial drugs. The patent details anti-malarial alkaloid compounds with specific formulas, wherein R-R have various disclosed values or their pharmaceutically acceptable salts. This invention also includes pharmaceutical compositions containing these compounds, showcasing Jossang's commitment to addressing malaria through scientific innovation.
Career Highlights
Throughout his career, Jossang has worked with prestigious institutions such as Université Pierre et Marie Curie (Paris VI) and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Jossang has collaborated with notable individuals, including François Frappier and Marie-Pierre Frappier, who serves as a Legal Representative. These partnerships have enriched his research and development efforts, fostering an environment of innovation.
Conclusion
Akino Jossang's work in developing anti-malarial drugs exemplifies the impact of innovation in healthcare. His contributions are vital in the ongoing fight against malaria, and his patent reflects a significant advancement in pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile